Molecular Diagnostics

Urine Prostate Cancer Screening Test Offers Best-In-Class Accuracy and Stratified Risk Assessment
A non-invasive, data-driven, urine prostate cancer screening test can provide highly accurate, stratified risk assessment insights to guide clinical decisions for patients with elevated prostate-specific antigen (PSA) or abnormal digital rectal exam (DRE) findings. More...07 Feb 2023

Nanotechnology-Based Blood Test Could Revolutionize Prostate Cancer Diagnosis
Researchers have developed a new nanotechnology-based test that can detect and profile prostate cancers - even in microscopic amounts. The “liquid biopsy” test can help patients avoid unnecessary treatment-related side effects and direct them instead to effective therapies that could extend their life span. More...06 Feb 2023

New Device Detects Brain Tumors Using Urine
Researchers have used a new device to identify a key membrane protein in urine that indicates whether a person has a brain tumor. By using the protein to detect brain cancer, it will be possible to avoid invasive tests and increase the chances of the tumor being detected at an early enough stage for surgery. More...06 Feb 2023


Real-Time PCR System Advances Large Reaction Volume IVD Assay Development and Diagnostic Testing
Amidst the ongoing increase in demand for efficient and flexible IVD real-time PCR systems, a new real-time PCR system advances large reaction volume IVD assay development and diagnostic testing. More...02 Feb 2023
Focused-Ultrasound-Mediated Liquid Biopsy to Facilitate Diagnosis of Neurodegenerative Disorders
New research has found that using focused-ultrasound-mediated liquid biopsy in a mouse model released more tau proteins and another biomarker into the blood than without the intervention. This noninvasive method could aid the diagnosis of neurodegenerative disorders, according to the researchers. More...01 Feb 2023

Blood Test Predicts Alzheimer's Risk 3.5 Years Before Clinical Diagnosis
A new study has found that a blood-based test can predict the risk of Alzheimer’s disease up to 3.5 years before clinical diagnosis. The study is based on the idea that components in the human blood are capable of modulating the formation of new brain cells, a process called neurogenesis which occurs in the hippocampus that plays a role in learning and memory. More...30 Jan 2023
In Other News
Novel Biomarker-Based Tests to Predict Response to Drugs for Treatment of Chronic Kidney Disease
Newly Identified Protein Biomarkers in Blood Predict Sudden Cardiac Arrest Before it Strikes
Blood Test Identifies Osteoarthritis Progression More Accurately than Current Methods
New DNA Biosensor Could Make High-Quality Clinical Diagnostics More Accessible
New Technique Enables Measurement of Thousands of Molecules from Single Blood Drop
Non-Invasive Blood Test Helps Select Treatment for Advanced Gastrointestinal Stromal Tumors
Non-Invasive Melanoma Test Ushers in New Era in Skin Cancer Detection
World’s First Molecular, Cell-Based Test Offers Non-Surgical Method for Diagnosis and Staging of Endometriosis
Rapid POC Diagnostic Assay Could Detect and Measure Fentanyl Neutralizing Antibodies
Molecular Diagnostic Platform for Automated Sample Processing to Help Labs Achieve New Flexibility Level
Early Alzheimer’s Detection Sensor Could Also Diagnose Other Diseases at POC
First-Of-A-Kind Pan-Cancer Blood Test Could Predict Immunotherapy Efficacy and Toxicity
World’s First Test Detects Diabetics at Risk of Kidney Disease before Symptoms Appear
ELISAs Reliably Detect Anti-CCHFV Antibodies in Acute Infections
New Blood Test Tracks and Follows Neurodegeneration in Alzheimer's
Electrochemical Cell-Free Biosensor Directly Detects Influenza Antibodies in Blood at POC
Highly Accurate Test "Fishes" For Respiratory Viruses Using DNA as Bait
Cheap, Easy Blood Test Detects Cancer by Identifying Broken DNA
Simple Blood Test Could Screen for Common and Dangerous Pregnancy Complications
Genetic Test Improves Ovarian Cancer Treatment
Blood Test Could Detect Alzheimer's 10 Years Before Symptoms Show
Blood Microbiome-Driven Liquid Biopsy Assay Detects Lung Cancer in Earliest Stages
BD, CerTest Announce Emergency Use Authorization for Mpox Diagnostic Test
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.







